Response Letter

Affiliations

Comment

Gail Lewis Phillips. Breast Cancer Res Treat. 2017 Sep.

. 2017 Sep;165(2):469-470.

doi: 10.1007/s10549-017-4352-z. Epub 2017 Jun 30.

¹ Molecular Oncology, Genentech, South San Francisco, CA, 94080, USA. gdl@gene.com.

No abstract available

Comment on

Trastuzumab uptake and its relation to efficacy in an animal model of HER2-positive breast cancer brain metastasis.
Lewis Phillips GD, Nishimura MC, Lacap JA, Kharbanda S, Mai E, Tien J, Malesky K, Williams SP, Marik J, Phillips HS. Lewis Phillips GD, et al. Breast Cancer Res Treat. 2017 Aug;164(3):581-591. doi: 10.1007/s10549-017-4279-4. Epub 2017 May 10. Breast Cancer Res Treat. 2017. PMID: 28493046 Free PMC article.
Antibody-based therapies for the treatment of brain metastases from HER2-positive breast cancer: time to rethink the importance of the BBB?
Askoxylakis V, Kodack DP, Ferraro GB, Jain RK. Askoxylakis V, et al. Breast Cancer Res Treat. 2017 Sep;165(2):467-468. doi: 10.1007/s10549-017-4351-0. Epub 2017 Jun 22. Breast Cancer Res Treat. 2017. PMID: 28643019 No abstract available.